266 related articles for article (PubMed ID: 9640999)
1. Efficacy studies of alprazolam in panic disorder.
Spiegel DA
Psychopharmacol Bull; 1998; 34(2):191-5. PubMed ID: 9640999
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
Jonas JM; Cohon MS
J Clin Psychiatry; 1993 Oct; 54 Suppl():25-45; discussion 46-8. PubMed ID: 8262888
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.
Moylan S; Staples J; Ward SA; Rogerson J; Stein DJ; Berk M
J Clin Psychopharmacol; 2011 Oct; 31(5):647-52. PubMed ID: 21869686
[TBL] [Abstract][Full Text] [Related]
4. Subjective experience and attitudes towards participation in clinical trials among patients with anxiety disorders.
Klein E; Malel D; Zilberman I; Lenox RH
Isr J Psychiatry Relat Sci; 1997; 34(4):265-9. PubMed ID: 9409083
[TBL] [Abstract][Full Text] [Related]
5. Personality dimensions in panic disorder before and after effective treatment.
Starcevic V; Uhlenhuth EH
Anxiety; 1996; 2(2):95-8. PubMed ID: 9160608
[No Abstract] [Full Text] [Related]
6. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
[TBL] [Abstract][Full Text] [Related]
7. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
[TBL] [Abstract][Full Text] [Related]
8. Two cases of alprazolam-induced hyperprolactinemia in patients with panic disorder.
Shioiri T; Kita N; Takahashi S
Int Clin Psychopharmacol; 1996 Jun; 11(2):149-52. PubMed ID: 8803653
[No Abstract] [Full Text] [Related]
9. The role of alprazolam for the treatment of panic disorder in Australia.
Moylan S; Giorlando F; Nordfjærn T; Berk M
Aust N Z J Psychiatry; 2012 Mar; 46(3):212-24. PubMed ID: 22391278
[TBL] [Abstract][Full Text] [Related]
10. Growing placebo response rate: the problem in recent therapeutic trials?
Uhlenhuth EH; Matuzas W; Warner TD; Thompson PM
Psychopharmacol Bull; 1997; 33(1):31-9. PubMed ID: 9133749
[TBL] [Abstract][Full Text] [Related]
11. Xanax XR for panic disorder.
Med Lett Drugs Ther; 2003 May; 45(1157):43-4. PubMed ID: 12766702
[No Abstract] [Full Text] [Related]
12. Generalized anxiety disorder versus panic disorder: participation in controlled efficacy trials.
Mavissakalian MR; Zamar N
Compr Psychiatry; 2000; 41(4):253-8. PubMed ID: 10929792
[TBL] [Abstract][Full Text] [Related]
13. The speed of onset of action of alprazolam-XR compared to alprazolam-CT in panic disorder.
Sheehan DV; Sheehan KH; Raj BA
Psychopharmacol Bull; 2007; 40(2):63-81. PubMed ID: 17514187
[TBL] [Abstract][Full Text] [Related]
14. [The efficacy of alprazolam in the therapy of panic disorders].
Diukova GM; Vorob'eva OV; Petrova EP; Smirnov SV; Tumalaeva ZN
Zh Nevrol Psikhiatr Im S S Korsakova; 1995; 95(4):9-13. PubMed ID: 8533521
[TBL] [Abstract][Full Text] [Related]
15. Issues in the assessment of treatment response in panic disorder with special reference to fluvoxamine.
Ninan PT
J Clin Psychiatry; 1997; 58 Suppl 5():24-31. PubMed ID: 9184624
[TBL] [Abstract][Full Text] [Related]
16. Cognitive-behavioral therapy for benzodiazepine discontinuation in panic disorder patients.
Otto MW; Pollack MH; Meltzer-Brody S; Rosenbaum JF
Psychopharmacol Bull; 1992; 28(2):123-30. PubMed ID: 1355299
[TBL] [Abstract][Full Text] [Related]
17. Decreased plasma cortisol level during alprazolam treatment of panic disorder: a case report.
Fukuda M; Takazawa S; Nakagome K; Iwanami A; Hata A; Kasai K; Hiramatsu K
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):909-15. PubMed ID: 9723127
[TBL] [Abstract][Full Text] [Related]
18. Long-term management of panic disorder.
Pollack MH
J Clin Psychiatry; 1990 May; 51 Suppl():11-3; discussion 50-3. PubMed ID: 1970813
[TBL] [Abstract][Full Text] [Related]
19. Diazepam versus alprazolam for the treatment of panic disorder.
Noyes R; Burrows GD; Reich JH; Judd FK; Garvey MJ; Norman TR; Cook BL; Marriott P
J Clin Psychiatry; 1996 Aug; 57(8):349-55. PubMed ID: 8752017
[TBL] [Abstract][Full Text] [Related]
20. Medication discontinuation in panic disorder.
Ballenger JC; Pecknold J; Rickels K; Sellers EM
J Clin Psychiatry; 1993 Oct; 54 Suppl():15-21; discussion 22-4. PubMed ID: 8262887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]